233 related articles for article (PubMed ID: 3184967)
1. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
[TBL] [Abstract][Full Text] [Related]
2. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
Chambers DJ; Takahashi A; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
[TBL] [Abstract][Full Text] [Related]
3. Long-term hypothermic storage of the mammalian heart for transplantation: a comparison of three cardioplegic solutions.
Galiñanes M; Murashita T; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):624-35. PubMed ID: 1498125
[TBL] [Abstract][Full Text] [Related]
4. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
6. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
[TBL] [Abstract][Full Text] [Related]
7. Functional recovery of hearts after cardioplegia and storage in University of Wisconsin and in St. Thomas' Hospital solutions.
Choong YS; Gavin JB
J Heart Lung Transplant; 1991; 10(4):537-46. PubMed ID: 1911796
[TBL] [Abstract][Full Text] [Related]
8. Cardioplegia: relation of myocardial protection to infusion volume and duration.
Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
Eur J Cardiothorac Surg; 1989; 3(2):130-3; discussion 134. PubMed ID: 2627463
[TBL] [Abstract][Full Text] [Related]
9. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.
Robinson LA; Harwood DL
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium aspartate on the recovery of the rat heart from long-term hypothermic storage.
Galiñanes M; Chambers DJ; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):521-31. PubMed ID: 1545551
[TBL] [Abstract][Full Text] [Related]
11. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
Ledingham SJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
[TBL] [Abstract][Full Text] [Related]
12. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.
Robinson LA; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150
[TBL] [Abstract][Full Text] [Related]
13. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
Yang SS; Hearse DJ
Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
[TBL] [Abstract][Full Text] [Related]
14. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution.
von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH
J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts.
Qiu Y; Hearse DJ
J Thorac Cardiovasc Surg; 1992 May; 103(5):960-8. PubMed ID: 1569777
[TBL] [Abstract][Full Text] [Related]
17. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection.
Galiñanes M; Hearse DJ
Cardioscience; 1990 Jun; 1(2):127-43. PubMed ID: 2102801
[TBL] [Abstract][Full Text] [Related]
18. Protection of the chronic hypoxic immature rat heart during global ischemia.
Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
[TBL] [Abstract][Full Text] [Related]
19. Protection of the immature myocardium. An experimental evaluation of topical cooling, single-dose, and multiple-dose administration of St. Thomas' Hospital cardioplegic solution.
Magovern JA; Pae WE; Waldhausen JA
J Thorac Cardiovasc Surg; 1988 Sep; 96(3):408-13. PubMed ID: 3411985
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three cardioplegic solutions during hypothermic ischemic arrest in neonatal blood-perfused rabbit hearts.
Konishi T; Apstein CS
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1132-7. PubMed ID: 2586132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
